Beijing Succeeder Technology Inc - Asset Resilience Ratio
Beijing Succeeder Technology Inc (688338) has an Asset Resilience Ratio of 28.27% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2025)
This chart shows how Beijing Succeeder Technology Inc's Asset Resilience Ratio has changed over time. Check 688338 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Beijing Succeeder Technology Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688338 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥502.71 Million | 28.27% |
| Total Liquid Assets | CN¥502.71 Million | 28.27% |
Asset Resilience Insights
- Very High Liquidity: Beijing Succeeder Technology Inc maintains exceptional liquid asset reserves at 28.27% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Beijing Succeeder Technology Inc Industry Peers by Asset Resilience Ratio
Compare Beijing Succeeder Technology Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM |
Medical Devices | 46.67% |
|
Allmed Solutions Ltd
TA:ALMD |
Medical Devices | 80.03% |
|
Universal Biosensors Inc
AU:UBI |
Medical Devices | 14.72% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Annual Asset Resilience Ratio for Beijing Succeeder Technology Inc (2024–2025)
The table below shows the annual Asset Resilience Ratio data for Beijing Succeeder Technology Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 28.34% | CN¥500.39 Million ≈ $73.22 Million |
CN¥1.77 Billion ≈ $258.35 Million |
+16.89pp |
| 2024-12-31 | 11.45% | CN¥200.21 Million ≈ $29.30 Million |
CN¥1.75 Billion ≈ $255.88 Million |
-- |
About Beijing Succeeder Technology Inc
Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and… Read more